Literature DB >> 27103114

Building Effective Quality Improvement Programs for Liver Disease: A Systematic Review of Quality Improvement Initiatives.

Elliot B Tapper1.   

Abstract

BACKGROUND & AIMS: Quality indicators are the measurable components of clinical standards. Data are limited about the design and impact of interventions to improve quality indicators for patients with chronic liver disease.
METHODS: A systematic review of PubMed, Web of Science, and conference proceedings was performed to find reports of quality improvement (QI) interventions. Data regarding the several indicators were collected. The search focused on vaccination against hepatitis A or hepatitis B virus, management of spontaneous bacterial peritonitis, screening for varices, management of acute variceal hemorrhage, hepatocellular carcinoma screening, and 30-day readmissions.
RESULTS: Fifteen studies reported on the results of QI interventions. Ten focused on specific quality indicators (1 specific to vaccination, 2 spontaneous bacterial peritonitis, 3 gastrointestinal bleeding, and 4 hepatocellular carcinoma screening); 5 focused on clinical outcomes. Most studies used a pre-post study design. Interventions included checklists, educational conferences, electronic decision supports, nurse coordinators, and systematic changes to facilitate specialist co-management. Successful interventions optimized clinical workflow, closed knowledge gaps among frontline providers, created forced functions in the electronic ordering system, added dedicated staff to manage specific indicators, and provided viable alternatives to hospitalization to reduce readmission. Unsuccessful interventions included case management, phone calls, and home visits to reduce readmissions, checklists, and educational programs.
CONCLUSIONS: Past experience with QI provides generalizable rules for successful future interventions aimed at improved quality indicator adherence and patient outcomes.
Copyright © 2016 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cirrhosis; Hepatic Encephalopathy; Hepatocellular Carcinoma; Paracentesis; Readmissions; Vaccination

Mesh:

Year:  2016        PMID: 27103114     DOI: 10.1016/j.cgh.2016.04.020

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  15 in total

1.  Concise Commentary: Remaining Outside the Hospital Is a Golden State in Cirrhosis-Lessons from California.

Authors:  Jasmohan S Bajaj; David Ross
Journal:  Dig Dis Sci       Date:  2018-09       Impact factor: 3.199

2.  Coordination of Care Is Associated With Survival and Health Care Utilization in a Population-Based Study of Patients With Cirrhosis.

Authors:  Shirley Cohen-Mekelburg; Akbar K Waljee; Brooke C Kenney; Elliot B Tapper
Journal:  Clin Gastroenterol Hepatol       Date:  2020-01-09       Impact factor: 11.382

Review 3.  Contemporary Epidemiology of Cirrhosis.

Authors:  Jad A Baki; Elliot B Tapper
Journal:  Curr Treat Options Gastroenterol       Date:  2019-06

4.  Quality Measures, All-Cause Mortality, and Health Care Use in a National Cohort of Veterans With Cirrhosis.

Authors:  Marina Serper; David E Kaplan; Justine Shults; Peter P Reese; Lauren A Beste; Tamar H Taddei; Rachel M Werner
Journal:  Hepatology       Date:  2019-06-26       Impact factor: 17.425

5.  Dos and Don'ts in the Management of Cirrhosis: A View from the 21st Century.

Authors:  Mary J Thomson; Elliot B Tapper; Anna S F Lok
Journal:  Am J Gastroenterol       Date:  2018-03-09       Impact factor: 10.864

6.  The Quality and Outcomes of Care Provided to Patients with Cirrhosis by Advanced Practice Providers.

Authors:  Elliot B Tapper; Shengchen Hao; Menghan Lin; John N Mafi; Heather McCurdy; Neehar D Parikh; Anna S Lok
Journal:  Hepatology       Date:  2019-06-21       Impact factor: 17.425

7.  An Electronic Decision Support Intervention Reduces Readmissions for Patients With Cirrhosis.

Authors:  Jeremy Louissaint; Katie Grzyb; Linda Bashaw; Rima A Mohammad; Neehar D Parikh; Elliot B Tapper
Journal:  Am J Gastroenterol       Date:  2022-03-01       Impact factor: 12.045

8.  Low Rates of Retesting for Eradication of Helicobacter pylori Infection After Treatment in the Veterans Health Administration.

Authors:  Shria Kumar; David C Metz; David E Kaplan; David S Goldberg
Journal:  Clin Gastroenterol Hepatol       Date:  2020-04-06       Impact factor: 11.382

Review 9.  The Future of Quality Improvement for Cirrhosis.

Authors:  Elliot B Tapper; Neehar D Parikh
Journal:  Liver Transpl       Date:  2021-07-31       Impact factor: 6.112

10.  A Quality Improvement Initiative Results in Improved Rates of Timely Postvariceal Bleeding Surveillance Endoscopy.

Authors:  Andrew M Moon; Hannah P Kim; A Sidney Barritt; Jama Darling; Shifali Arora
Journal:  Am J Gastroenterol       Date:  2020-04       Impact factor: 12.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.